Clinical Trial Update: [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating [18F]FMISO PET/CT after transcatheter arterial embolization in adult liver cancer patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer
• Liver Cirrhosis

Drugs mentioned

• 18F-FMISO (fluoromisonidazole)

Snippet

Sponsor: Stanford University | Conditions: Adult Liver Carcinoma, Liver Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-22